OSLO, Norway, Aug. 23, 2019 /PRNewswire/ -- With reference to the previous notification of trade, the correct number of shares purchased today, 23 August 2019, by Malene Brondberg is not 1,722 shares, but 3,900 shares in Nordic Nanovector ASA (the "Company") at an average share price of NOK 25.38 per share. Following this transaction, Malene Brondberg owns 9,455 shares in the Company and holds 40,000 PSUs.
This information is subject to duty of disclosure pursuant to Section 4-2 and Section 5-2 of the Norwegian Securities Trading Act.
For further information, please contact: IR enquiries Malene Brondberg, VP Investor Relations and Corporate Communications Cell: +44-7561-431-762 Email: [email protected]
Media Enquiries Mark Swallow/David Dible (Citigate Dewe Rogerson) Tel: +44-207-638-9571 Email: [email protected]
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ? Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...
